BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33710655)

  • 61. C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis.
    Ishida N; Higuchi T; Miyazu T; Tamura S; Tani S; Yamade M; Iwaizumi M; Hamaya Y; Osawa S; Furuta T; Sugimoto K
    Sci Rep; 2021 Jun; 11(1):12431. PubMed ID: 34127687
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Accuracy of Diffusion-weighted Magnetic Resonance Colonography in Assessing Mucosal Healing and the Treatment Response in Patients with Ulcerative Colitis.
    Laurent V; Naudé S; Vuitton L; Zallot C; Baumann C; Girard-Gavanier M; Peyrin-Biroulet L
    J Crohns Colitis; 2017 Jun; 11(6):716-723. PubMed ID: 27932450
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Endoscopic and histologic response to cyclosporine in ulcerative colitis and their impact on disease outcome: A cohort study.
    Fron C; Pierry C; Poullenot F; Chabrun E; Subtil C; Capdepont M; Zerbib F; Belleannée G; Laharie D
    Dig Liver Dis; 2016 Jul; 48(7):734-9. PubMed ID: 27052254
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
    Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
    Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Application of Deep Learning Models to Improve Ulcerative Colitis Endoscopic Disease Activity Scoring Under Multiple Scoring Systems.
    Byrne MF; Panaccione R; East JE; Iacucci M; Parsa N; Kalapala R; Reddy DN; Ramesh Rughwani H; Singh AP; Berry SK; Monsurate R; Soudan F; Laage G; Cremonese ED; St-Denis L; Lemaître P; Nikfal S; Asselin J; Henkel ML; Travis SP
    J Crohns Colitis; 2023 Apr; 17(4):463-471. PubMed ID: 36254822
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Potential utility of a new ulcerative colitis segmental endoscopic index combining disease severity and the extent of inflammation.
    Suzuki Y; Uchiyama K; Kato M; Matsuo K; Nakagawa T; Kishikawa H; Kimura N; Kasanuki J; Ino S
    J Clin Gastroenterol; 2015; 49(5):401-6. PubMed ID: 25127112
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation of ex vivo cytokine secretion profiles with scoring indices in ulcerative colitis.
    Podolski M; Požgaj L; Faraho I; Petrinić Grba A; Belamarić D; Paravić Radičević A; Bosnar M; Crnčević Urek M; Čubranić A; Mustapić S; Mijandrušić-Sinčić B; Banić M; Eraković Haber V
    Eur J Clin Invest; 2023 Dec; 53(12):e14070. PubMed ID: 37547943
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Endocytoscopy can be used to assess histological healing in ulcerative colitis.
    Nakazato Y; Naganuma M; Sugimoto S; Bessho R; Arai M; Kiyohara H; Ono K; Nanki K; Mutaguchi M; Mizuno S; Kobayashi T; Hosoe N; Shimoda M; Abe T; Inoue N; Ogata H; Iwao Y; Kanai T
    Endoscopy; 2017 Jun; 49(6):560-563. PubMed ID: 28472831
    [No Abstract]   [Full Text] [Related]  

  • 69. Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis.
    Asonuma K; Kobayashi T; Nakano M; Sagami S; Kiyohara H; Matsubayashi M; Morikubo H; Miyatani Y; Okabayashi S; Yamazaki H; Kuroki Y; Hibi T
    Inflamm Bowel Dis; 2022 Feb; 28(2):200-207. PubMed ID: 33847348
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Autofluorescence imaging endoscopy for identification and assessment of inflammatory ulcerative colitis.
    Osada T; Arakawa A; Sakamoto N; Ueyama H; Shibuya T; Ogihara T; Yao T; Watanabe S
    World J Gastroenterol; 2011 Dec; 17(46):5110-6. PubMed ID: 22171146
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Endoscopic and Histological Mucosal Healing in Ulcerative Colitis in the First Year of Diagnosis: Results from a Population-based Inception Cohort from Six Countries in Asia.
    Leung CM; Tang W; Kyaw M; Niamul G; Aniwan S; Limsrivilai J; Wang YF; Ouyang Q; Simadibrata M; Abdullah M; Ong DE; Yu HH; Zhang J; Ching J; Wu JCY; Chan FKL; Sung JJY; Ng SC
    J Crohns Colitis; 2017 Dec; 11(12):1440-1448. PubMed ID: 28961760
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
    Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis.
    Kawashima K; Ishihara S; Yuki T; Fukuba N; Oshima N; Kazumori H; Sonoyama H; Yamashita N; Tada Y; Kusunoki R; Oka A; Mishima Y; Moriyama I; Kinoshita Y
    BMC Gastroenterol; 2016 Apr; 16():47. PubMed ID: 27071448
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study.
    Kim ES; Lee HS; Kim SK; Kim EY; Jang BI; Kim KO; Yang CH; Lee YJ;
    Scand J Gastroenterol; 2020 Feb; 55(2):163-168. PubMed ID: 31984815
    [No Abstract]   [Full Text] [Related]  

  • 75. Common laboratory blood test immune panel markers are useful for grading ulcerative colitis endoscopic severity.
    Cui J; Li X; Zhang Z; Gao H; Li J
    BMC Gastroenterol; 2022 Dec; 22(1):540. PubMed ID: 36572872
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impact of Endoscopic and Histologic Activity on Disease Relapse in Ulcerative Colitis.
    Bessissow T; Kron CM; Marcus V; Lemieux C; Laneuville J; Afif W; Wild G; Lakatos PL; Brassard P; Bitton A
    Am J Gastroenterol; 2022 Oct; 117(10):1632-1638. PubMed ID: 35862833
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neutrophil-only Histological Assessment of Ulcerative Colitis Correlates with Endoscopic Activity and Predicts Long-term Outcomes in a Multicentre Study.
    Parigi TL; Cannatelli R; Nardone OM; Zammarchi I; Shivaji U; Furfaro F; Zardo D; Spaggiari P; Del Sordo R; Setti O; Majumder S; Smith SCL; Danese S; Armuzzi A; Villanacci V; Ghosh S; Iacucci M
    J Crohns Colitis; 2023 Dec; 17(12):1931-1938. PubMed ID: 37390319
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients.
    Lobatón T; Bessissow T; De Hertogh G; Lemmens B; Maedler C; Van Assche G; Vermeire S; Bisschops R; Rutgeerts P; Bitton A; Afif W; Marcus V; Ferrante M
    J Crohns Colitis; 2015 Oct; 9(10):846-52. PubMed ID: 26116558
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing.
    Jangi S; Yoon H; Dulai PS; Valasek M; Boland BS; Jairath V; Feagan BG; Sandborn WJ; Singh S
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1008-1016. PubMed ID: 33119168
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Beyond complete endoscopic healing: Goblet appearance using an endocytoscope to predict future sustained clinical remission in ulcerative colitis.
    Takishima K; Maeda Y; Ogata N; Misawa M; Mori Y; Homma M; Nemoto T; Miyata Y; Akimoto Y; Mochida K; Takashina Y; Tanaka K; Ichimasa K; Nakamura H; Sasanuma S; Kudo T; Hayashi T; Wakamura K; Miyachi H; Baba T; Ishida F; Ohtsuka K; Kudo SE
    Dig Endosc; 2022 Jul; 34(5):1030-1039. PubMed ID: 34816494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.